Generic semaglutide is now part of Canada's medication landscape. For patients, the important question is what that changes at the pharmacy: which product is being offered, what it is authorized for, whether it can fill the prescription, and what it will actually cost.
This guide separates the 2026 approvals from current supply questions and explains the specific product recall to check before relying on an older availability article.
The quick answer: Canada approved generic semaglutide products in 2026, including products referencing Ozempic and Wegovy. They do not all have the same indication or market status. Check the exact product, DIN and pharmacy supply. A late-August recall concerns specified Dr. Reddy's Semaglutide Injection products and lots; it is not a recall of every semaglutide medicine.
What Canada approved in 2026
| Date | What happened | Why it matters |
|---|---|---|
| April 28 | Health Canada authorized Dr. Reddy's generic semaglutide injection referencing Ozempic. | The approval concerned adult type 2 diabetes treatment. |
| May 1 | Health Canada approved an Apotex generic semaglutide injection for type 2 diabetes. | Another authorized product entered the Canadian landscape. |
| June 29 | Health Canada authorized Apotex's Sevmia, referencing Wegovy. | This approval concerned chronic weight management under its monograph. |
See Health Canada's April announcement, May announcement and June announcement. These dates describe authorization, not guaranteed stock in every pharmacy.
Is generic Wegovy available?
Sevmia is an authorized generic referencing Wegovy. The Sevmia record checked on September 6, 2026 showed Approved, with a status date of June 29, 2026. That record alone does not establish pharmacy availability.
Ask the pharmacist to check the exact prescribed product and presentation. A clinic's waitlist, a product announcement and a pharmacy's ability to fill a prescription are different things.
Check the late-August Dr. Reddy's recall
Health Canada's notice, updated August 26 and showing an original publication date of August 27, identifies an impurity problem affecting Dr. Reddy's Semaglutide Injection:
| DIN | Lots identified in the notice |
|---|---|
| 02567806 | 7000544, 7000545, 7000546 |
| 02567814 | 7000542, 7000543, 7000624, 7000628, 7000629 |
Check the official recall notice against the package. Ask your pharmacist for help identifying an affected product and arranging next steps. Health Canada advises consulting a healthcare provider before discontinuing an affected product. This notice does not describe all brands, all manufacturers or all semaglutide products as recalled.
What “generic” actually tells you
Health Canada evaluates generic submissions against requirements for safety, efficacy and quality. Its semaglutide announcements describe these products as complex synthetic generics referencing brand-name biologic drugs. The practical takeaway is to check the authorized finished product, rather than judge a medicine only by the ingredient on a website.
An authorized generic and a compounded preparation follow different regulatory pathways. A seller calling a product “generic,” “custom” or “the same ingredient” is not sufficient evidence that Health Canada authorized that finished product. Read our peptide and product-verification guide for the distinction.
Five things to confirm before comparing prices
- The product name and manufacturer. Ask for the exact name on the dispensing label.
- The DIN. Record the eight-digit number and match it to the Drug Product Database.
- The prescription and presentation. Have the pharmacist confirm whether that product can fill your prescription.
- The quantity and supply period. Compare equal periods, including dispensing fees.
- The final amount you pay. Ask for the price after your actual benefits have been assessed.
Keep the date of the quote. If the product is unavailable, ask when the pharmacy expects to know more rather than treating an estimated arrival date as a promise.
Will generic semaglutide cost less?
Generic competition can affect prices, but the savings for one prescription depend on the product, quantity, pharmacy fees and benefit plan. Broad statements about how much cheaper generics can be do not establish a semaglutide price for a particular BC patient.
Use a like-for-like request: “Please quote the total for this exact prescription and supply period, including the dispensing fee, and show my share after insurance.” A membership price that excludes medication should be compared separately.
The cost and coverage guide gives you a comparison worksheet and a worked budgeting example. It also explains why a drug's coverage for diabetes does not automatically apply to weight management.
What should I ask my insurer?
Send the product's DIN and ask whether it is covered under your plan for the prescribed use. Request the answer in writing if possible. Useful follow-up questions include:
- Is prior authorization needed for this DIN?
- Does the plan require a particular generic product?
- Does changing product require a new form or prescription?
- Is there a weight-management exclusion or a separate annual maximum?
- When does any approval begin, and when does it expire?
Your pharmacist can help interpret the dispensing side of the answer. Your prescriber handles changes to clinical treatment.
If a seller offers it without a prescription
A prescription medicine should come through a licensed care and pharmacy pathway. Health Canada warns about fake or unauthorized GLP-1 products sold online and on social media. Read its consumer advisory if a seller promises easy access without a clinical assessment or cannot identify the dispensing pharmacy.
Your next step
Get the free product-verification checklist and use it during a pharmacy call. If you are still learning the difference between products, start with the BC GLP-1 guide.
Frequently asked questions
Does generic semaglutide mean generic Ozempic or generic Wegovy?
It can refer to different products. Check the exact brand, manufacturer and monograph rather than assuming that all products share the same indication.
Can I switch automatically?
Ask the pharmacist and prescriber. The appropriate product depends on your prescription, presentation and applicable dispensing rules. A website cannot authorize a switch.
Does the recall affect every generic?
The notice identifies particular Dr. Reddy's products and lots. Match your package to the notice or ask your pharmacist to check it.
Does Health Canada approval guarantee insurance coverage?
No. Authorization and benefit coverage are separate. Confirm your plan's decision using the exact DIN.
Free generic semaglutide verification checklist
Keep the product name, DIN, recall check, pharmacy quote and insurance response together in one printable worksheet.
This guide provides general information, not a prescribing or substitution decision. Sources were checked September 6, 2026; product and supply information can change.